Labetuzumab (marketed under the trade name CEA-CIDE) is a humanized IgG1 monoclonal antibody for the treatment of colorectal cancer. It selectively binds...
2 KB (92 words) - 23:53, 17 July 2024
| U | V | W | X | Y | Z La | Le | Lf–Ln | Lo | Ls–Ly labetalol (INN) labetuzumab (INN) Labid (Warner Chilcott) labradimil (USAN) Lac-Hydrin lacidipine...
4 KB (281 words) - 04:55, 21 August 2024
Antigen (KMA) multiple myeloma Keliximab mab chimeric CD4 chronic asthma Labetuzumab CEA-Cide mab humanized Carcinoembryonic antigen (CEA) colorectal cancer...
137 KB (4,083 words) - 21:25, 19 October 2024
with Seagen that led to the resignation of founder David M. Goldenberg. Labetuzumab (IMMU-130) is an anti-CEACAM5-SN-38 antibody-drug conjugate in clinical...
5 KB (401 words) - 02:08, 20 September 2024
Gemtuzumab ozogamicin Glofitamab Imgatuzumab§ Inotuzumab ozogamicin Labetuzumab§ Lifastuzumab vedotin§ Lintuzumab§ Lorvotuzumab mertansine§ Lumretuzumab§...
4 KB (241 words) - 13:42, 14 July 2024
Gemtuzumab ozogamicin Glofitamab Imgatuzumab§ Inotuzumab ozogamicin Labetuzumab§ Lifastuzumab vedotin§ Lintuzumab§ Lorvotuzumab mertansine§ Lumretuzumab§...
5 KB (368 words) - 15:29, 21 August 2024
Gemtuzumab ozogamicin Glofitamab Imgatuzumab§ Inotuzumab ozogamicin Labetuzumab§ Lifastuzumab vedotin§ Lintuzumab§ Lorvotuzumab mertansine§ Lumretuzumab§...
3 KB (129 words) - 01:04, 19 July 2023